Anti-diabetic treatment regulates pro-fibrotic TGF-β serum levels in type 2 diabetics

BACKGROUND: The single-center, open-label, four-arm, exploratory study investigates the relation of different anti-diabetics to serum levels of active TGF-β, a known pro-fibrotic stimulus, before and after a defined test meal. FINDINGS: We investigated sera of patients with type 2 diabetes mellitus...

Descripción completa

Detalles Bibliográficos
Autores principales: Pscherer, Stefan, Freude, Thomas, Forst, Thomas, Nussler, Andreas K, Braun, Karl F, Ehnert, Sabrina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847073/
https://www.ncbi.nlm.nih.gov/pubmed/24004910
http://dx.doi.org/10.1186/1758-5996-5-48

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847073/
https://www.ncbi.nlm.nih.gov/pubmed/24004910
http://dx.doi.org/10.1186/1758-5996-5-48

Ejemplares similares